Winning Health Technology Group Co Ltd
SZSE:300253

Watchlist Manager
Winning Health Technology Group Co Ltd Logo
Winning Health Technology Group Co Ltd
SZSE:300253
Watchlist
Price: 12.1 CNY -13.2% Market Closed
Market Cap: 26.8B CNY
Section:
 

Relative Value

The Relative Value of one Winning Health Technology Group Co Ltd stock under the Base Case scenario is 8.15 CNY. Compared to the current market price of 12.1 CNY, Winning Health Technology Group Co Ltd is Overvalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
8.15 CNY
Overvaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

12.4
P/S
P/S
Price to Sales
12.4
vs History
11
vs Industry
17
Median 3Y
6.9
Median 5Y
7.2
Industry
2.4
Forward
9.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
6
Median 3Y
47.7
Median 5Y
61.4
Industry
22.9
Forward
86.7
More Details
53.5
P/OCF
P/OCF
Price to OCF
53.5
vs History
53
vs Industry
3
Median 3Y
59.3
Median 5Y
67
Industry
14.7
More Details
111.9
P/FCFE
P/FCFE
Price to FCFE
111.9
vs History
28
vs Industry
0
Median 3Y
80.4
Median 5Y
81.6
Industry
21.4
More Details
4.6
P/B
P/B
Price to Book Value
4.6
vs History
23
vs Industry
19
Median 3Y
3.3
Median 5Y
3.8
Industry
2.3
More Details
12.4
EV/S
EV/S
Enterprise Value to Sales
12.4
vs History
11
vs Industry
15
Median 3Y
6.9
Median 5Y
7.4
Industry
2.6
Forward
9.1
More Details
36.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
36.6
vs History
0
vs Industry
10
Median 3Y
16.2
Median 5Y
17.3
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
6
Median 3Y
85.2
Median 5Y
70.5
Industry
12.3
Forward
59.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
8
Median 3Y
85.2
Median 5Y
70.5
Industry
17.2
Forward
52
More Details
53.6
EV/OCF
EV/OCF
Enterprise Value to OCF
53.6
vs History
53
vs Industry
3
Median 3Y
59.5
Median 5Y
67.8
Industry
15
More Details
110.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
110.5
vs History
47
vs Industry
0
Median 3Y
79.9
Median 5Y
123.6
Industry
19
More Details
4
EV/IC
EV/IC
Enterprise Value to IC
4
vs History
23
vs Industry
23
Median 3Y
2.9
Median 5Y
3.3
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Winning Health Technology Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Winning Health Technology Group Co Ltd
SZSE:300253
26.8B CNY 12.4 -86.9 -171.8 -171.8
US
Veeva Systems Inc
NYSE:VEEV
36.3B USD 11.8 42.2 32 33.4
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
21.2B AUD 96.1 184 127 127
JP
M3 Inc
TSE:2413
1.4T JPY 4.3 30.8 15.7 19.3
US
Doximity Inc
NYSE:DOCS
7.7B USD 12.4 30.5 26.5 27.7
US
Waystar Holding Corp
NASDAQ:WAY
5.3B USD 5.1 47.6 16 25
SE
Sectra AB
STO:SECT B
45.7B SEK 20.4 70.7 -139.6 -139.6
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
291.9B INR 11 60.1 37.4 43.6
US
Heartflow Inc
NASDAQ:HTFL
3B USD 0 0 0 0
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD 3.2 62.9 50.3 67.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Average EV/EBITDA: 40.8
Negative Multiple: -171.8
36%
N/A
US
Veeva Systems Inc
NYSE:VEEV
32
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
127
32%
4
JP
M3 Inc
TSE:2413
15.7
14%
1.1
US
Doximity Inc
NYSE:DOCS
26.5
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
16
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -139.6 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.4
24%
1.6
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
50.3
85%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Average EV/EBIT: 48.3
Negative Multiple: -171.8
47%
N/A
US
Veeva Systems Inc
NYSE:VEEV
33.4
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
127
31%
4.1
JP
M3 Inc
TSE:2413
19.3
N/A N/A
US
Doximity Inc
NYSE:DOCS
27.7
25%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
25
58%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -139.6 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.6
26%
1.7
US
H
Heartflow Inc
NASDAQ:HTFL
Not Available N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
67.5
34%
2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.